|
Pharmacology and Toxicology of Leflunomide
|
Ram Lal Lodhi   , Shubhini A. Saraf , Gaurav Kaithwas , Sudipta Saha |
|
|
|
Abstract: (1452 Views) |
| Leflunomide (LEF), used for rheumatoid arthritis, inhibits dihydro-orotate dehydrogenase (DHODH) and tyrosine kinase (TK) enzymes and has anti-inflammatory, lymphocyte proliferation regulatory, immunosuppression and chondroprotective effects. The most common adverse effects are gastrointestinal disorders, weight loss, hypertension, skin infection, and neurological and hematological toxicity. It also produces hepatotoxicity and teratogenic effects on long term therapy. The Food and Drug Administration (FDA) categorized it as black box warning drug since 2010. Therefore, it is necessary to give toxicological informations to scientific communities. This review article is elaborately describes the toxicity of this drug during its long and short term therapies. |
|
| |
|
|
Full-Text [PDF 265 kb]
(891 Downloads)
|
|
Article Type: Research Article |
|
|
|
|
|
|
|
| Add your comments about this article |
|
|
|
